GanleeFine is a disposable sterile injection device used in conjunction with most of commercially available injection pens for subcutaneous injection of drugs (insulin, liraglutide and recombinant human growth hormone*). GanleeFine is designed with ultra-thin wall of needle tube to reduce injection pain; it covers 4mm, 6mm and 8mm to meet the injection needs of patients with different body sizes.
*Liraglutide injection and recombinant human growth hormone injection are only for disposable injection pen needles.
· GanleeFine is sterilized by ethylene oxide and wrapped individually. DO NOT use GanleeFine if the packaging is damaged.
· DO NOT reuse the needles. After being used, GanleeFine should be discarded per local regulations of waste disposal.
· DO NOT change the angle during injection; otherwise, the needle might be broken. If the needle is broken under your skin, please go to a doctor immediately.
Try to choose a short needle (4-6 mm). Generally, the shorter needle is much safer and has better tolerance. Conversely, the longer the needle is, the higher the risk of intramuscular injection will be.
*Please follow the advice of your doctor or healthcare professional to determine which specification of GanleeFine® is the most suitable for you.
Because the 4 mm needle injects the subcutaneous tissue by injecting it into the skin vertically, the risk of intramuscular (or intradermal) injection is minimal. The 4mm needle is the safest pen needle for adults and children, regardless of age, gender, and body mass index (BMI). Young children and very thin adults should use a 4 mm needle with a vertical skin pinching. For other people, there is no need to pinch the skin when using a 4 mm needle for injection. Regardless of whether the skin is pinched, the 4 mm needle should be inserted vertically.
Normal and obese adults do not need to pinch the skin and insert the needle vertically. However, for children and thin adults, they need to pinch the skin and insert the 6 mm needle vertically.
General body shape patients need to pinch the skin and inject at 45° or vertically. However, to ensure that insulin is injected into the subcutaneous tissue, it can also be injected at 45° without pinching the skin to increase the thickness of the subcutaneous tissue and reduce the risk of injection into the muscle.
*The above information is for reference only. Please always follow your doctor or healthcare professional’s instructions.
Please enter the email address used for registration to receive password reset messages
We sent an email to XXXXXXXXXXX@qq.com with a link to reset the password. If you don't get one, try checking your spam folder.